New Delhi: A total of 24 blockbuster drugs, with global sales worth $251 billion, have lost or are set to lose their patents in the US by 2030, which could …
New Delhi: Pharmaceutical companies should not organise conferences for doctors in foreign locations, offer gifts for personal benefit of any healthcare professional or their family members, extend hospitality like hotel stay, expensive cuisine, …
New Delhi: Several organisations working to promote access to life-saving drugs on Wednesday warned if the final text of the India and the European Free Trade Association (EFTA) agreement retained …
As a result, the government faced an uphill task of fixing the nation’s image and restoring the credibility of generics produced in the country. Beginning 2023, the government announced a …
New Delhi: A new report by a network of multinational pharma companies and a leading consulting firm has said that the Indian pharmaceutical market should aim to achieve a size …
New Delhi: Government initiatives to remove centrally unapproved and banned antibiotic fixed-dose combination (FDC) drugs have remained largely ineffective, and in 2020, most of the antibiotic formulations sold in India …